Overall, all-grade TRAEs were very common, with diarrhea (66.8%), rash (66.7%), and paronychia (42.0%) being the most frequent, consistent with the typical toxicity spectrum of EGFR inhibitors targeting classical mutations (Zhao et al., 2019). This evidence concerns the gene EGFR and paronychia.